Moreover, Npas4 expression was reported to decrease in parallel with the progression of Alzheimer’s disease (AD), particularly at Braak neurofibrillary tangle (NFT) stages I-II, corresponding to lesion development in transentorhinal/entorhinal cortex (Miyashita et al., 2014). This evidence concerns the gene NPAS4 and Alzheimer disease.